Answers are grounded in this paper and cite their sources.
In 1997, more than 40 new medicinal chemical entities in the field of anti-infectives were presented during the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, held in Toronto. Among these novelties, three compounds could or will be candidates for clinical development: HMR 3647, a ketolide derivative; T-3811, a new quinolone; and GM 237,354, a new antifungal compound. Other molecules are potential lead compounds.
No takes yet. Share an insight, caveat, or question.
A. Bryskier (1998) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: